Proposed approaches for the treatment of cancers with P53 mutations involve the use of small molecules for the restoration of WT P53 function, P53 stabilization by inhibiting its interaction with negative regulators (such as MDM2 and MDMX), and activation of P53 family members such as P73 (18–20). This evidence concerns the gene TP53 and cancer.